Zhaoting Meng

1.5k total citations · 1 hit paper
29 papers, 993 citations indexed

About

Zhaoting Meng is a scholar working on Oncology, Molecular Biology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Zhaoting Meng has authored 29 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Zhaoting Meng's work include Lung Cancer Research Studies (8 papers), Intensive Care Unit Cognitive Disorders (7 papers) and Anesthesia and Sedative Agents (6 papers). Zhaoting Meng is often cited by papers focused on Lung Cancer Research Studies (8 papers), Intensive Care Unit Cognitive Disorders (7 papers) and Anesthesia and Sedative Agents (6 papers). Zhaoting Meng collaborates with scholars based in China, United States and United Kingdom. Zhaoting Meng's co-authors include Dong‐Xin Wang, Daqing Ma, Fan Cui, Xinhai Wu, Sainan Zhu, Hong-Liang Li, Mervyn Maze, Xian Su, Xi Zhu and Jing Ma and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhaoting Meng

27 papers receiving 983 citations

Hit Papers

Dexmedetomidine for prevention of delirium in elderly pat... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoting Meng China 11 648 519 427 178 112 29 993
Fan Cui China 9 598 0.9× 484 0.9× 385 0.9× 163 0.9× 131 1.2× 25 872
Xia Shen China 16 407 0.6× 387 0.7× 426 1.0× 92 0.5× 124 1.1× 57 879
Michael Hueppe Germany 13 249 0.4× 220 0.4× 215 0.5× 233 1.3× 328 2.9× 25 1.1k
Xuezhao Cao China 17 278 0.4× 68 0.1× 234 0.5× 73 0.4× 110 1.0× 40 826
Hajime Takase Japan 18 127 0.2× 91 0.2× 149 0.3× 90 0.5× 153 1.4× 76 942
Dong Woo Han South Korea 18 169 0.3× 498 1.0× 135 0.3× 312 1.8× 414 3.7× 92 991
Mazhong Zhang China 15 183 0.3× 344 0.7× 139 0.3× 90 0.5× 126 1.1× 48 630
Maxim Rachinsky Israel 12 100 0.2× 83 0.2× 149 0.3× 131 0.7× 123 1.1× 21 721
Zac Hana United Kingdom 5 240 0.4× 116 0.2× 233 0.5× 61 0.3× 39 0.3× 7 419
George Mychaskiw United States 15 98 0.2× 151 0.3× 135 0.3× 113 0.6× 112 1.0× 39 811

Countries citing papers authored by Zhaoting Meng

Since Specialization
Citations

This map shows the geographic impact of Zhaoting Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoting Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoting Meng more than expected).

Fields of papers citing papers by Zhaoting Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoting Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoting Meng. The network helps show where Zhaoting Meng may publish in the future.

Co-authorship network of co-authors of Zhaoting Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoting Meng. A scholar is included among the top collaborators of Zhaoting Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoting Meng. Zhaoting Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Peng, Li‐Ling, Rui Zhou, Yan Zhong, et al.. (2023). [18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects. European Journal of Nuclear Medicine and Molecular Imaging. 50(12). 3723–3734. 3 indexed citations
4.
Deng, Chun-Mei, Zhaoting Meng, Jing Yang, et al.. (2023). Effect of intraoperative remimazolam on postoperative sleep quality in elderly patients after total joint arthroplasty: a randomized control trial. Journal of Anesthesia. 37(4). 511–521. 8 indexed citations
6.
Zhang, Cuicui, Jing Wang, Xinyue Wang, et al.. (2021). Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer. Cancer Biology and Medicine. 19(8). 1249–1258. 4 indexed citations
7.
Wang, Jingya, Tao Sun, Zhaoting Meng, et al.. (2021). XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a. Cancer Letters. 503. 197–212. 33 indexed citations
9.
Zhang, Lingyu, Tianbin Song, Zhaoting Meng, et al.. (2020). Correlation between apparent diffusion coefficients and metabolic parameters in hypopharyngeal squamous cell carcinoma: A prospective study with integrated PET/MRI. European Journal of Radiology. 129. 109070–109070. 9 indexed citations
10.
Meng, Zhaoting, Fan Cui, Xueying Li, & Dong‐Xin Wang. (2019). Epidural morphine improves postoperative analgesia in patients after total knee arthroplasty: A randomized controlled trial. PLoS ONE. 14(7). e0219116–e0219116. 8 indexed citations
11.
Su, Xian, Zhaoting Meng, Fan Cui, et al.. (2019). Handover of anesthesia care is associated with an increased risk of delirium in elderly after major noncardiac surgery: results of a secondary analysis. Journal of Anesthesia. 33(2). 295–303. 6 indexed citations
12.
Zhang, Danfeng, Xian Su, Zhaoting Meng, et al.. (2018). Impact of Dexmedetomidine on Long-term Outcomes After Noncardiac Surgery in Elderly: 3-Year Follow-up of a Randomized Controlled Trial. Annals of Surgery. 270(2). 356–363. 60 indexed citations
13.
Meng, Zhaoting, et al.. (2018). [A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation 
Treated with Anlotinib].. SHILAP Revista de lepidopterología. 21(5). 428–430. 6 indexed citations
14.
Meng, Zhaoting, Peng Chen, Fenglin Zang, et al.. (2017). A patient with classic biphasic pulmonary blastoma harboring<em> CD74&ndash;ROS1</em> fusion responds to crizotinib. OncoTargets and Therapy. Volume 11. 157–161. 10 indexed citations
15.
Mu, Dong-Liang, Dazhi Zhang, Dong‐Xin Wang, et al.. (2017). Parecoxib Supplementation to Morphine Analgesia Decreases Incidence of Delirium in Elderly Patients After Hip or Knee Replacement Surgery: A Randomized Controlled Trial. Anesthesia & Analgesia. 124(6). 1992–2000. 62 indexed citations
16.
Zhang, Danfeng, Xian Su, Zhaoting Meng, et al.. (2017). Preoperative severe hypoalbuminemia is associated with an increased risk of postoperative delirium in elderly patients: Results of a secondary analysis. Journal of Critical Care. 44. 45–50. 29 indexed citations
17.
Su, Xian, Zhaoting Meng, Xinhai Wu, et al.. (2016). Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. The Lancet. 388(10054). 1893–1902. 523 indexed citations breakdown →
18.
Wu, Xinhai, Fan Cui, Cheng Zhang, et al.. (2016). Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit. Anesthesiology. 125(5). 979–991. 147 indexed citations
19.
Meng, Zhaoting, Yadong Wang, Yanfeng Yan, et al.. (2011). Identification of an HLA-DPB1*0501 Restricted Melan-A/MART-1 Epitope Recognized by CD4+ T Lymphocytes. Journal of Immunotherapy. 34(7). 525–534. 3 indexed citations
20.
Jiao, Shunchang, et al.. (2010). Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients. Journal of Experimental & Clinical Cancer Research. 29(1). 38–38. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026